Radiotherapy With Pembrolizumab in Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
University of Erlangen-Nürnberg Medical School
University of Erlangen-Nürnberg Medical School
University of Washington
Pfizer
Pfizer
Novartis
MacroGenics
Flamingo Therapeutics NV
M.D. Anderson Cancer Center
Royal Marsden NHS Foundation Trust
University of Arizona
Ocellaris Pharma, Inc.
Fusion Pharmaceuticals Inc.
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Alpha Tau Medical LTD.
Takeda
Gilead Sciences
AbbVie
HiFiBiO Therapeutics
M.D. Anderson Cancer Center
EMD Serono
Novartis
Sanofi
Pfizer
Incyte Corporation
Novartis
3B Pharmaceuticals GmbH
Ascendis Pharma A/S
Yale University
NuCana plc
Telix Pharmaceuticals (Innovations) Pty Limited
invoX Pharma Limited
Eli Lilly and Company
Formation Biologics
PhytoHealth Corporation
Numab Therapeutics AG
Regeneron Pharmaceuticals
Groupe Oncologie Radiotherapie Tete et Cou
Thomas Jefferson University
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Seagen Inc.
Turnstone Biologics, Corp.
Regeneron Pharmaceuticals
Shattuck Labs, Inc.
Alentis Therapeutics AG
University of California, San Francisco
Seagen Inc.
OHSU Knight Cancer Institute
Sotio Biotech Inc.
M.D. Anderson Cancer Center